Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002484 · ClinicalTrials.gov registry record · Phase 1

Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer

A Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
Phase 1
Development phase
104
Enrollment target

NCT00002484: Completed Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00002484 is a Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002484, a Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
Phase 1
Development phase
104 participants
Enrollment target

Study Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Computer systems that allow doctors to create a 3-dimensional picture of the tumor in order to plan treatment may result in more effective radiation therapy. PURPOSE: Phase I trial to study the effectiveness of high-dose radiation therapy planned using a 3-dimensional picture of the tumor in treating patients who have stage I, stage II, or stage III non-small cell lung cancer.

Interventions

  • RADIATION radiation therapy

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 1991-10
Phase Phase 1

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT00002484

The ClinicalTrials.gov registry entry for NCT00002484 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which radiation therapy is the first listed.

NCT00002484 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00002484 about?

NCT00002484 is a clinical study titled "Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Computer systems that allow doctors to create a 3-dimensional picture of the tumor in order to plan treatment may result in more effective radiation therapy. PURPOSE: Phase I trial to study the effectiveness of high-dose ra...

What is the current status of trial NCT00002484?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 104 participants. The study started on 1991-10.

What interventions are being tested in trial NCT00002484?

The interventions under investigation include: radiation therapy (RADIATION).

Who is sponsoring clinical trial NCT00002484?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.